2ND GLOBAL CONGRESS FOR CONSENSUS IN PEDIATRICS & CHILD HEALTH
The 2nd Global Congress for Consensus in Pediatrics & Child Health”, will take place on May 17-20, 2012 in Moscow, Russia.
The Congress is being held with the participation of the American Academy of Pediatrics (AAP), Canadian Paediatric Society (CPS) and International Pediatric Association (IPA).
The scientific program will be of the highest standard, featuring presentations by leaders and opinion makers in the fields of pediatric specialties, presented in keynote addresses, sharp state of the art lectures, controversial debates and exclusive symposia.
Congress website: www.cipediatrics.org
WSPID 2011 SCIENTIFIC PROGRAM
Wed Nov 16
08.45-16.30. Educational workshop for fellows (whole day, max 30 fellows, pre-registration necessary)
08.30-10.00 ANZPID society symposium
1. Infectious encephalitis. Cheryl Jones, Australia
2. Kuru. Michael Alpers, Australia
3. Otitis media in Indigenous children. Amanda
Leach, Australia
4. State of NZ child health: an uncontrolled infectious disease burden in the 21st century in an OECD country. Diana Lennon, New Zealand
18.40-20.00 Welcome Reception and Opening Ceremony
David Isaacs and Shabir Madhi
Thur Nov 17
07.15-08.00
Meet the Professor 1
TB Steve Graham, Australia
Meet the Professor 2
How to write a paper. Nigel Curtis, Australia
Meet the Professor 3
Otitis media Ron Dagan, Israel
08.15-09.45 WSPID symposium 1 (plenary. Pneumonia (30 mins per talk.
Chair: Shabir Madhi and Michael Nissen
1. Challenges in the management and prevention of pneumonia in a resource poor setting. Zulfi Bhutta, Pakistan
2. Diagnosis and management of pneumonia in industrialized settings in the era of vaccination. Kathy Edwards, USA
3. Unraveling the pathogenesis and etiology of pneumonia with pneumococcal conjugate vaccines. Shabir Madhi, South Africa
09.45-10.15 Coffee/Posters
10.15-11.30
PIDS society symposium
Accelerating Movement of New Vaccines into Under Resourced Areas of the World
Chair:
1. Group A polysaccharide-tetanus toxoid conjugate vaccine for Africa: A model for vaccine development against ‘neglected’ diseases .F. Marc LaForce, USA
2. Rotavirus vaccine: Getting an effective vaccine to where it is needed the most. Penelope H. Dennehy, USA
3. Developing, producing, and distributing influenza vaccine in a pandemic: Who is in charge, and how can it be done better next time? Ralf Clemens, USA
ANZPID society symposium
Planning to take the panic out of the next pandemic: a dramatic hypothetical.
Chair: Tom Snelling, Australia and Jonathan Carapetis, Australia
11.30-12.30
Oral Poster presentation 1
Chair: Adriano Aguedas, Costa Rica and Shai Ashkenazi, Israel
Oral Poster presentation 2
Chair: Ron Dagan, Israel and Angela Gentile, Argentina
12.30-13.30 Lunch
13.30-14.45
WSPID mini-symposium 1: Antibiotic resistance
Chair: Heikki Peltola, Finland and Nigel Curtis, Australia
1. Perspectives on the cause, management and control of resistant S. pneumoniae, Keith Klugman, USA
2. The global epidemic of resistant Staphylococcal infection and approaches to treatment. Sheldon Kaplan, USA
3. How to simplify the treatment of severe bacterial infections. Heikki Peltola, Finland
Consensus symposium 1
Hot Topics in the Diagnosis and Treatment of Invasive Fungal Infections in Children and Neonates
Chair: Maria Santolaya, Chile
1. Introduction and Objectives
2. Neonatal Candidiasis: Antifungal Prophylaxis and Treatment. T. Zaoutis, USA
3. Risk Factors and Diagnosis of Invasive Candidiasis and Invasive Aspergillosis in Children. M.E. Santolaya, Chile
4. Newer Antifungal Strategies for Treating Pediatric Invasive Aspergillosis. W.J. Steinbach, USA
14.45-15.15 Coffee/Posters
15.15-16.45
Sponsored symposium 5 Crucell
16.45-17.15 Ice cream break
17.15-18.45
Sponsored symposium 6 Novartis
Fri Nov 18
07.00-07.45
Meet the Professor 4
Meningitis. Heikki Peltola, Finland Meet the Professor 5
Paediatric HIV. Ram Yogev, USA and Hermione Lyall, United Kingdom
Meet the Professor 6
Infection Control. Lisa Saiman, USA
08.00-10.00
WSPID symposium 2
Vaccines for developing countries
Chair: Andrew Pollard and Kathy Edwards
1. Vaccine Advocacy Gus Nossal, Australia
2. How do vaccines work Andrew J Pollard, United Kingdom
3. Improved TB vaccines: Are we there yet?. Greg Hussey, South Africa
4. Implementing pneumonia prevention – looking forwards Kim Mulholland, United Kingdom
WSPID symposium 3
Emerging infections 1
Chair: Jim Buttery and Zulfi Bhutta
1. Overview. Ted Tsai, USA
2. An epidemic of novel viruses: what is the clinical relevance? Albert Osterhaus, The Netherlands
3. Challenges in management and prevention of MDRTB. Ben Marais, South Africa
4. Threat from emerging respiratory viral infections. Steve Graham, Australia
10.00-10.30 Coffee/Posters
10.30-11.45
ESPID Symposium
Viral infections in children – evidence based management
Chair:
1. RSV infection: current and future prevention and treatment. Jan Kimpen, The Netherlands
2. Seasonal and pandemic flu in children: prevention and treatment in healthy and high risk children. Irja Lutsar, Estonia
3. Rotavirus infection after the introduction of vaccines. Philippe Lepage, Belgium
AfSPID symposium
Serious infections in children
Chair: Kikelomo Osinusi and Mark Cotton
1. Neonatal Infections – perspectives from Morocco. Abdemlmounaim Aboussad, Morocco
2. Update on malaria epidemiology and prevention in African children. Fred Were, Kenya
3. Childhood Tuberculosis: Situation and Control Efforts in Africa. Osawaru Oviawe, Nigeria
4. HIV – in children: How are we doing? Addy Kekitiinwa, Uganda
11.45-12.30
WSPID special lecture. Ron Dagan, Israel
Chair: Shabir Madhi
12.30-13.15 Lunch
13.15-14.25
Consensus symposium 2
Pediatric UTI - management and prevention in 2011
Chair Shai Ashkenazi, Israel
1. Introduction and objectives
2. Antibiotic treatment of paediatric UTI. Sheldon Kaplan, USA
3. Imaging in a child with UTI (ultrasound, renal scan, cystography?). Shai Ashkenazi, Israel
4. Antibiotic prophylaxis for paediatric UTI. Jonathan Craig, Australia
14.25-15.20
Oral Poster presentation 3
Chair: Mike Starr, Australia and Javier Diez-Domingo, Spain
Oral Poster presentation 4
Chair: Oana Falup-Pecurariu, Romania and Edwin Asturias, Guatemala
15.20-15.45 Coffee break
15.45-17.15
Sponsored symposium 7 Pfizer
17.15-17.40 Ice cream break
17.40-19.10
Sponsored Symposium 8 GSK
20.00 Faculty dinner
Sat Nov 19
07.15-08.00
Meet the Professor 7
Gastroenteritis. Miguel O’Ryan, Chile
Meet the Professor 8
Rapid diagnosis/Point of care diagnosis. David Murdoch, New Zealand
Meet the Professor 9
Vaccine safety . Ulrich Heininger, Switzerland
08.15-09.45
WSPID symposium 4
Group A Streptococcal infections
Chair: Mike Levin, United Kingdom and Jonathan Carapetis, Australia
1. Group A streptococcal infection, prevention and control. Jonathan Carapetis, Australia
2. How Molecular Epidemiology Can Help Us Understand Strep Pharyngitis. Stan Shulman, USA
3. Group A Streptococcal vaccines. Jim Dale, USA
09.45-10.15 Coffee/Posters
10.15-11.30
ASPID symposium
Dengue
Chair: Ping-Ing Lee and Usa Thisyakorn
1. Dengue: A Global Concern - Overview: Usa Thisyakorn, Thailand
2. Immunopathogenesis: Huan Yao Lei, Taiwan
3. A New Classification: Sri Rezeki H Hadinegoro, Indonesia
SLIPE society symposium
Relevant Topics in Pediatric Infectious Diseases: Lessons from the Latin America and the Caribbean Experience and Research.
Chair: Miguel O´Ryan and Carla Odio
1. Clinical Research in Developing Countries: Opportunities, Barriers and Challenges". Juan Pablo Torres, Chile
2. Sepsis Neonatal in Latin America: tackling a Millenium Developmental Objective in the region. Xavier Sáez Llorens, Panamá
3. Challenges in the prevention and treatment of perinatal HIV infection in Latin America and the Caribbean. Rosa Bologna, Argentina
4. Current Status on Immunization Practices in Latin America and the Caribbean: Are we meeting our needs in poor resource countries and regions? José I. Santos, México
11.30-12.30
World Lecture Peter Doherty, Australia
Chair: Shabir Madhi and David Isaacs
12.30-13.30 Lunch/Posters
13.30-14.40
WSPID mini-symposium 2
Kawasaki disease
Chair: Stan Shulman, USA and David Burgner, Australia
1. Understanding the cause of Kawasaki disease: are we there yet? Anne Rowley, USA
2. Genetics of Kawasaki disease. David Burgner, Australia
3. Management of KD and its complications: What works? Jane Burns, USA
WSPID mini-symposium 3
Emerging infections 2
Chair: Ulrich Heininger, Switzerland and Mike Starr, Australia
1. Taking a global perspective on control of important bacterial disease through the Gates Foundation. Richard Adegbola, Nigeria
2. Emerging Viral Encephalitides. Tom Solomon, United Kingdom
3. Re-emergence of pertussis. Ulrich Heininger, Switzerland
14.40-16.10
WSPID mini-symposium 4: Molecular approaches to diagnosis in host and bug
Chair: Mike Levin, United Kingdom and David Murdoch, New Zealand
1. Molecular diagnosis of pneumonia and PERCH. David Murdoch, New Zealand
2. The signature of infection in the USA. Octavio Ramillo, USA
3. The signature of infection in Africa. Mike Levin, United Kingdom
SLIPE symposium 2
Addressing The Challenges of Emerging Pathogens In Latin America"
Chair: Greta Miño, Ecuador and Adriano Arguedas, Costa Rica
1. Haemophilus influenzae disease burden in Latin America and the Caribbean. David Prado, Guatemala
2. S. pneumoniae infections in Latin America: Epidemiology and prevention. Adriano Arguedas, Costa Rica
3. Epidemiological and clinical features of Epstein Barr virus infection in Latin America and the Caribbean. Napoleón González, Mexico
4. Clinical features and outcome of severe dengue in Latin America and the Caribbean. José Brea, Dominican Republic
16.10-16.35 Ice cream break
16.35- 18.05
WSPID symposium 5
Neonatal infections
Chairs Cheryl Jones, and David Isaacs, Australia
1. What should I do about neonatal fungal infection. David Isaacs, Australia
2. Neonatal sepsis in resource poor settings. Samir Saha, Bangla Desh
3. Control of Group B Streptococcal infection. Carol Baker, USA
18.05-19.00
Awards, Cultural Event and reception
Chair Shabir Madhi and David Isaacs
SPONSORSHIP AND EXHIBITION WSPID 2011.
Pharmaceutical companies, booksellers and other institutions are invited to participate in the 7th World Congress of WSPID in 2011, Melbourne, Australia.
A sponsorship- and exhibition brochure can be downloaded from here. This brochure containes all information on organization of sponsored symposia, packages for international and local sponsors, on individual sponsorship items, exhibition facilities, prices, registration, booking, conditions, addresses, etcetera.
ONLINE EDUCATION
We are happy to inform you that WSPID has started with an educational program on PID. It will consist of 6 modules with CME accreditation and it is prepared by experts on pediatric infectious diseases.
Please go to Links of this website and click on "ONLINE EDUCATION"
or go directly to
www.pediatric-respiratory-infection.com
WSPID 2011 REGISTRATION AND ACCOMMODATION
Registration forms and details on accommodation, please visit the website
www.kenes.com/wspid
1ST ANNOUNCEMENT WSPID 2011
Dear Friends and Colleagues,
It is my pleasure to welcome you to the 7th World Congress on Pediatric Infectious Diseases which will take place in Melbourne, Australia, November 16-19, 2011.
We invite you to attend this congress, where renowned speakers will fascinate us with the latest discoveries in our field, and ample time will be provided for discussion, interaction and social activities in a friendly and congenial environment.
Come join your colleagues in pediatric infectious diseases from around the world, present your latest discoveries and gain insight from theirs.
We look forward to welcoming you in Melbourne for WSPID 2011.
Yours sincerely,
Shabir Madhi, MD
President, World Society for Pediatric Infectious Diseases
Congress Venue
Melbourne Convention Exhibition Centre
1 Convention Centre Pl, South Wharf 3006
Melbourne, Australia
Website: www.mcec.com.au
Language
The official language of the congress is English.
Sponsorship and Exhibition
Pharmaceutical companies are invited for sponsorship and exhibition during the Congress. Details on sponsorship items, satellite symposia, workshops and exhibition facilities can be found in the Brochure for sponsors. Potential sponsors and exhibitors can request information from
Prof Mieke Hoogkamp-Korstanje, secretary general of WSPID, e-mail: m.hoogkamp@xs4all.nl.
Accommodation
Kenes International is the official travel agent for WSPID 2009 and will be offering special reduced rates for accommodation as well as pre and post tours. Further information will be available on the
official website and in the Second Announcement.
Abstracts
All abstracts will be accepted and published in the abstract book.
They will be judged for oral or poster presentation
Important dates
Submission of abstracts June 10, 2011
Notification of presentation form July 15, 2011
Early registration fee July 29, 2011
Registration fees in USD
Full Registration Fee (from countries on list A)*
until July 29, 2011: $440
from July 30, 2011: $660
Reduced Registration Fee (from countries on list B)*
until July 29, 2011: $170
from July 30, 2011: $350
Local Fellows, Students and Nurses
until July 29, 2011: $110
from July 30, 2011: $200
* for a complete listing of countries please refer to the website www.kenes.com/wspid
WSPID Secretariat
Prof. Mieke Hoogkamp-Korstanje
Heyenseweg 48, 6591 HD Gennep
The Netherlands
Tel: +31 485 51 9146
Fax: +31 485 51 4040
E-mail: m.hoogkamp@xs4all.nl
Homepage: www.wspid.com
Congress Secretariat
Kenes International / WSPID 2009
1-3 Rue du Chantepoulet, PO Box 1726
CH-1211 Geneva 1
Switzerland
Tel: +41 22 908 0488
Fax: +41 22 732 2850
E-mail: wspid@kenes.com
Preliminary program
Wednesday, November 16, 2009
• Arrival and registration
• Sponsored symposia
Thursday, November 17 - Saturday, November 19, 2011
• Plenary sessions with topics of global interest
• Symposia by international and national societies
• Consensus meetings
• Sponsored symposia
• Meet the Professor sessions
• Free papers
• Poster sessions
• World Congress Lecture
Main Topics
• Ambulatory Management of Invasive Infections
• Antibiotics and drug resistance
• Bacterial infections
• Bone, joint and soft tissue infections
• Central nervous system infections
• Congenital and perinatal infections
• Day-care associated infections
• Diagnosis and monitoring of infectious diseases
• Emerging infections
• Epidemiology
• Fungal infections
• Gastro-intestinal infections
• Global networking in PID
• Governmental commitment
• HIV/AIDS
• Hospital and health-care associated infections
• Immunology
• Infections in the immunocompromised host
• Infections in migrants and travellers
• Influenza including avian flu
• Modalities and indications for old and new drugs
• Parasitic infections
• Research and development
• Respiratory tract infections
• Sepsis and septic shock
• Surgical infections
• Urinary tract infections
• Vaccines and prevention
• Viral infections
• Zoonoses
